UnitedHealth Group has leveraged its clinical knowledge, expertise and resources to help develop and advance innovations to fight COVID-19. Our teams have developed new types of testing modules and worked with partners to support the advancement of potential treatments and building of life-saving equipment.
We helped improve access to monoclonal antibody treatment and further measure its effectiveness for patients with mild to moderate COVID-19 symptoms.
We collaborated with Johnson & Johnson and its Janssen Pharmaceutical Companies to support their Phase 3 COVID-19 vaccine candidate trial.
We donated $5 million to accelerate and expand Mayo Clinic’s groundbreaking investigational study of convalescent plasma treatments for COVID-19 patients nationwide.
New Light Ventilators
Testing Materials and Protocols
Broad, rapid and accurate testing is essential to addressing the COVID-19 crisis. UnitedHealth Group has helped develop simple, scalable solutions to improve testing efficiency and flexibility, and protect health care workers.
Polyester and Saline Testing Materials
We led a study resulting in FDA approval for the use of alternative swab materials and commonly available saline for COVID-19 testing, providing more options for sample collection.
Self-Administered Swab Testing
We developed and tested a new FDA approved self-administered COVID-19 swab protocol that has led to meaningfully improved testing efficiency, safety and protection of health care workers, and reduced consumption of personal protection equipment.
Vaccine Information
COVID-19 vaccines are an important step in slowing the spread of the disease. Visit our FAQ for information on what to know about COVID-19 vaccines.
Download
-
UnitedHealth Group's COVID-19 Response